Literature DB >> 11331873

Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.

N A Cacalano1, D Sanden, J A Johnston.   

Abstract

Suppressors of cytokine signalling (SOCS, also known as CIS and SSI) are encoded by immediate early genes that act in a feedback loop to inhibit cytokine responses and activation of 'signal transducer and activator of transcription' (STAT). Here we show that SOCS-3 is strongly tyrosine-phosphorylated in response to many growth factors, including interleukin-2 (IL-2), erythropoietin (EPO), epidermal growth factor (EGF) and platelet-derived growth factor (PDGF). The principal phosphorylation sites on SOCS-3 are residues 204 and 221 at the carboxy terminus, and upon phosphorylation tyrosine 221 interacts with the Ras inhibitor p120 RasGAP. After IL-2 stimulation, phosphorylated SOCS-3 strongly inhibits STAT5 activation but, by binding to RasGAP, maintains activation of extracellular-signal-regulated kinase (ERK). A tyrosine mutant of SOCS-3 still blocks STAT phosphorylation, but also strongly inhibits IL-2-dependent activation of ERK and cell proliferation. Moreover, it also inhibits EPO- and PDGF-induced proliferation and ERK activation. Therefore, although SOCS proteins inhibit growth-factor responses, tyrosine phosphorylation of SOCS-3 can ensure cell survival and proliferation through the Ras pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331873     DOI: 10.1038/35074525

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  57 in total

1.  Can SOCS make arthritis better?

Authors:  Lionel B Ivashkiv; Ioannis Tassiulas
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

3.  SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Authors:  Lerin R Luckett-Chastain; Michael A Ihnat; Bethany M Mickle-Kawar; Randle Michael Gallucci
Journal:  J Interferon Cytokine Res       Date:  2012-02-07       Impact factor: 2.607

4.  Cerebral preconditioning using cortical application of hypertonic salt solutions: upregulation of mRNAs encoding inhibitors of inflammation.

Authors:  Hiromi Muramatsu; Frank A Welsh; Katalin Karikó
Journal:  Brain Res       Date:  2006-05-24       Impact factor: 3.252

Review 5.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

6.  SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases.

Authors:  Joanne Elliott; Yvonne Suessmuth; Linda M Scott; Krystyna Nahlik; Mary Frances McMullin; Stefan N Constantinescu; Anthony R Green; James A Johnston
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

7.  Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes.

Authors:  Hongwei Qin; Sandrine A Niyongere; Sun Jung Lee; Brandi J Baker; Etty N Benveniste
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Negative regulation of FAK signaling by SOCS proteins.

Authors:  Enbo Liu; Jean-François Côté; Kristiina Vuori
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

9.  SOCS3 deletion promotes optic nerve regeneration in vivo.

Authors:  Patrice D Smith; Fang Sun; Kevin Kyungsuk Park; Bin Cai; Chen Wang; Kenichiro Kuwako; Irene Martinez-Carrasco; Lauren Connolly; Zhigang He
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

10.  Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation.

Authors:  Jargalsaikhan Dagvadorj; Yoshikazu Naiki; Gantsetseg Tumurkhuu; Abu Shadat Mohammod Noman; Imtiaz Iftakhar-E-Khuda; Takayuki Komatsu; Naoki Koide; Tomoaki Yoshida
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.